Chemokine CCL2 induces apoptosis in cortex following traumatic brain injury (Q44426802)

2 December 2017

Chemokine CCL2 induces apoptosis in cortex following traumatic brain injury (English)

1 reference

2 December 2017

traumatic brain injury

0 references

author name string

Su Liu

1

1 reference

2 December 2017

Lixia Zhang

2

1 reference

2 December 2017

Qinfeng Wu

3

1 reference

2 December 2017

Qi Wu

4

1 reference

2 December 2017

Tong Wang

5

1 reference

2 December 2017

11 August 2013

1 reference

Journal of Molecular Neuroscience

2 December 2017

1 reference

2 December 2017

51

1 reference

2 December 2017

1021-1029

1 reference

2 December 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s12031-013-0091-8

2 December 2017

0 references

cites work

Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Brain-derived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

The cytokine temporal profile in rat cortex after controlled cortical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Responses to cortical injury: I. Methodology and local effects of contusions in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Motor and cognitive function evaluation following experimental traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Astrocyte- and endothelial-targeted CCL2 conditional knockout mice: critical tools for studying the pathogenesis of neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

The temporal expression, cellular localization, and inhibition of the chemokines MIP-2 and MCP-1 after traumatic brain injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

CCL2 modulates cytokine production in cultured mouse astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Formaldehyde impairs learning and memory involving the disturbance of hydrogen sulfide generation in the hippocampus of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Expression of adhesion molecules and monocyte chemoattractant protein -1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Calcium homeostasis following traumatic neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

Genetic and histologic evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0091-8

21 January 2018

Traumatic brain injury.

1 reference

12 December 2020

Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain

1 reference

12 December 2020

Acute Excitotoxic Injury Induces Expression of Monocyte Chemoattractant Protein-1 and Its Receptor, CCR2, in Neonatal Rat Brain

1 reference

12 December 2020

Neurorestorative treatments for traumatic brain injury

1 reference

12 December 2020

Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1

1 reference

12 December 2020

Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat.

1 reference

12 December 2020

Pathophysiology of traumatic brain injury

1 reference

12 December 2020

10.1007/S12031-013-0091-8

Identifiers

DOI

1 reference

2 December 2017

1 reference